CME vs. Mastercard: Which Financial Stock Is a Better Buy in 2026?

Investing in the financial world often means choosing between different types of market infrastructure. CME Group (NASDAQ:CME) and Mastercard (NYSE:MA) both provide essential platforms, but they operate in distinct corners of the global economy.

CME Group facilitates the trading of risk through its massive derivatives marketplace, while Mastercard powers the flow of consumer and commercial payments. Investors often compare these two because they both benefit from high barriers to entry and strong profitability. Choosing between them requires weighing the stability of exchanges against the rapid growth of digital transactions.

The case for CME

CME Group operates the world's leading marketplace for derivatives, offering futures and options through its CME, CBOT, NYMEX, and COMEX exchanges. Its customer base includes professional traders, financial institutions, and governments that use these tools to manage risk in agricultural, energy, and interest rate markets. Note that one clearing firm accounted for nearly 12% of its clearing and transaction fees, adding a layer of concentration risk.

In FY 2025, revenue reached nearly $6.5 billion, representing growth of approximately 6.4% over the previous year. Net income for the period was roughly $4.0 billion, resulting in a net margin of 62%. This reflects a steady expansion in profitability from the 57.8% net margin recorded in FY 2023 and the 57.5% reported in its FY 2024 financial statements.

As of its December 2025 balance sheet, the debt-to-equity ratio is approximately 0.1x. This ratio measures total debt relative to shareholders' equity, with lower ratios indicating a lighter debt load relative to owners' investment in the business. The company also reported a current ratio of 1.0x, indicating its short-term assets equal its immediate liabilities, and it generated roughly $4.2 billion in free cash flow.

The case for Mastercard

Mastercard connects financial institutions, merchants, and governments through its global payments network, placing it at the heart of the fintech stocks landscape. The company relies on five large customers for a significant portion of its revenue, and it manages relationships for billions of transactions in over 210 countries. Recently, it expanded its capabilities by acquiring BVNK to support stablecoin payments and Recorded Future for specialized threat intelligence services.

During FY 2025, Mastercard reported revenue of nearly $32.8 billion, a 16.4% increase from the previous fiscal year. Net income climbed to approximately $15.0 billion, yielding a net margin of 45.6%. This performance shows consistent high-level execution, as the net margin has remained relatively stable since the 45.7% mark achieved during FY 2024.

As of the December 2025 balance sheet, the company carries a debt-to-equity ratio of approximately 2.5x. This metric indicates that its total debt is two and a half times its shareholders' equity, a level it supports with strong recurring revenue. Mastercard also reported a current ratio of 1.0x, meaning its short-term assets match its short-term liabilities, while generating a robust $16.4 billion in free cash flow.

Risk profile comparison

CME Group faces significant competitive risks from global derivatives exchanges such as Intercontinental Exchange (NYSE:ICE) and Nasdaq (NASDAQ:NDAQ). Regulatory and compliance risks are extensive, especially regarding potential legislative changes to market structure or financial transaction taxes. Information security and operational resilience are also critical, as evidenced by a 2025 data center cooling failure that disrupted trading operations.

Mastercard contends with intense worldwide competition from other global payment networks like Visa (NYSE:V) and American Express (NYSE:AXP). The company is subject to significant legal scrutiny over interchange rates and antitrust compliance, which could result in fines or business restrictions. Additionally, it faces risks from global economic volatility and from governments favoring their own nationalized payment providers.

Valuation comparison

CME carries a lower Forward P/E, but both companies trade at an identical P/S ratio based on sales over the past twelve months.

Valuation metrics include those sourced from Financial Modeling Prep (FMP) and may differ from those of other data providers.

Which stock would I buy in 2026?

When comparing CME and Mastercard, investors should consider a few key factors. Let's have a look at them and see what that tells us about each stock.

To start, there's growth. In this case, the matchup reveals a battle between consistency and volatility. Mastercard has delivered quite consistent, average year-over-year revenue growth of 14.3% since 2024. CME, on the other hand, has averaged 9.5% revenue growth. However, its growth has been extremely volatile, ranging from a high of 19.2% to a low of -3%.

Another factor to consider is each company's profitability. Both have delivered exceptional profits, although CME has an advantage in this category. CME has averaged a 64.2% operating margin since 2024, a figure that has steadily increased. Mastercard, meanwhile, has averaged 58.4%. It too has consistently improved its profitability.

Last, there's valuation. Since both companies have delivered consistent profits, let's use price-to-earnings (P/E) to compare them. Mastercard has a P/E multiple of 33.8x, while CME's is 25.3x. That gives an edge to CME.

In summary, these two financial stocks have delivered solid revenue growth and profitability. However, in a head-to-head matchup, many investors may favor CME given its lower valuation and greater profitability. Yet, Mastercard shouldn't be overlooked. Its impressive growth and margins make it a stock that investors should still consider.

American Express is an advertising partner of Motley Fool Money. Jake Lerch has positions in Visa. The Motley Fool has positions in and recommends American Express, CME Group, Mastercard, and Visa. The Motley Fool recommends Intercontinental Exchange and Nasdaq. The Motley Fool has a disclosure policy.